tirzepatide on shortage list ๐จ Alert: No Longer FDA's Drug As of October 2, 2024, the FDA has announced that the Tirzepatide shortage has been resolved. This means that all doses of Compounders lose battle over Eli
Description
In HF with preserved ejection fraction and mildly reduced ejection fraction, semaglutide improved symptoms, physical function, natriuretic peptide levels, echocardiographic parameters, and HF hospitalizations, as shown in the STEP-HFpEF program and a pooled analysis of trials

Another flurry of media attention occurred as the drug became available, with news that supply couldn't keep up with demand

Predicting weight loss and side effects before treatment begins
13 companies
